To view our videos, you need to
enable JavaScript. Learn how.
install Adobe Flash 9 or above. Install now.

Then come back here and refresh the page.

CHARLOTTE – The pending delivery of the H1N1 vaccine has some groups speaking out against the inoculation.

“We don't know if this vaccine is going to be effective,” said Lisa Jillani, who leads PAVE – a North Carolina-based organization advocating for vaccine education. “With H1N1, it’s been rushed to the market and that makes me question its safety.”

New York health care workers protested mandatory H1N1 vaccination earlier this week, with some saying they aren’t sure the vaccine is safe for everyone.

“If a health care worker is hesitant to take it, then the average citizen should be even more diligent about reading the package insert and getting more information,” said Jillani, who feels the trend of mass inoculations of the seasonal and H1N1 flu is dangerous.

The Centers for Disease Control and the Federal Drug Administration have set up a vaccine safety surveillance system to track adverse side effects of H1N1 vaccines in real time. Such an H1N1 vaccine was stopped in the late 1970s because it was linked to a higher risk for Guillain-Barre Syndrome – a disorder occurring when the body’s immune system mistakenly attacks part of the nervous system.

The CDC even warns that people with severe allergies to chicken eggs or any other ingredient of the vaccine should not be vaccinated.

“They should know the pros and the cons,” said Jillani.

The director of the U.S. Department of Health and Human Services granted legal immunity to pharmaceutical manufacturers of the H1N1 vaccines. The move means pharmaceutical companies cannot be held liable in any lawsuits stemming from the vaccine.

Supporters of the move say, without immunity, drug makers wouldn’t have worked on creating a vaccine for fear of lawsuits.